Global Biochip Markets: Microarrays and Lab-on-a-Chip

List of Tables

The global market for biochip was valued at $16.1 billion in 2024 and is estimated to reach $27.8 billion by 2029, at a compound annual growth rate (CAGR) of 11.6% from 2024 through 2029.

The biochip equipment and software market for biochip was valued at $6.8 billion in 2024 and is estimated to reach $11.6 billion by 2029, at a CAGR of 11.3% from 2024 through 2029.

The microfluidic biochips (lab-on-a-chip) market for biochip was valued at $2.5 billion in 2024 and is estimated to reach $4.6 billion by 2029, at a CAGR of 12.6% from 2024 through 2029.

Report Scope

This report provides an overview of the global biochip market and analyzes market trends. The report includes global revenue ($ million) for the base year 2023 and estimated data for the forecast period 2024 through 2029. The market is segmented based on product type, technology, application, end user industry and region. The regions covered in this study include North America, Europe, Asia-Pacific and Rest of the World (South America, the Middle East and Africa), focusing on major countries in these regions.

The report focuses on the significant trends and challenges that affect the market and vendor landscape. It analyzes environmental, social and corporate governance (ESG) developments and discusses patents and emerging technologies related to the market.

The report concludes with an analysis of the competitive landscape, which provides the ranking and shares of key companies in the global biochip market. There is also a dedicated section on company profiles that provides details about leading companies in the market.

The company profiles offer detailed information about business segments, financials, product portfolios and recent developments. By geographical region, the market has been segregated into North America, Europe, Asia-Pacific and the Rest of World, which includes the Middle East, Africa and South America. The North American region covers the U.S., Canada and Mexico. Europe examines Germany, the U.K., Italy, France, Spain and the Rest of Europe. Asia-Pacific encompasses China, Japan, India, Australia, South Korea and the Rest of Asia-Pacific. For market estimates, data has been provided for 2021 and 2022 as the historic years, 2023 as the base year, with estimates for 2024 and a forecast for 2025 through 2029.

Report Includes

76 data tables and 56 additional tables
An analysis of the current and future global markets for biochip diagnostic products and technologies
Analyses of global market trends, with historic revenue data from 2021 to 2024, and projected CAGRs through 2029
Estimates of the size of and revenue prospects for the global biochip market, along with a market share analysis by product type, technology, application, end-user vertical, and region
Facts and figures pertaining to the market dynamics, technological advances, regulations, and the impact of macro-economic factors
A look at the major commercial biochip products and the future potential of each key market segment, emerging technologies, clinical trials, and other new developments
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading biotech companies
Analysis of the industry structure, including companies' market shares, strategic alliances, M&A activity, venture fundings and investment outlook
Company profiles of major players within the industry, including Abbott, Bio-Rad Laboratories Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., and BioMerieux

Product Code: BIO049G

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Overview and Market Definition
Technology Background
Technological Infrastructure and Data Integration

Chapter 3 Market Dynamics

Market Dynamics
Market Drivers
Rising Demand for Point-of-Care Diagnostics
Increasing Investment and Funding in Biochip and Microarray Research Activities
Increasing Prevalence of Cancer Generating Demand for Personalized Treatments
Market Restraints and Challenges
High Costs Associated with Developing and Implementing Biochip Technology
Technical Challenges
Market Opportunities
Technological Advances and Automation in the Biochip industry
Growing Volume of Clinical Research

Chapter 4 Regulatory Landscape

Market Regulations by Agency
The U.S.
Federal Regulation
CMS Regulation
FDA Regulation
FTC Regulation
Canada
European Union
The U.K.
China
Japan
Australia
International Standards and Guidelines

Chapter 5 Emerging Technologies and Developments

Artificial Intelligence in Biochip Technology for Biomedicine
Advances in DNA and Protein Microarrays
3D Microarrays and Organoid-on-a-Chip
Hydrogel-Based Microarrays
Other Types of 3D Microarrays

Chapter 6 Market Segmentation Analysis

Market Overview
Segmentation Breakdown
Global Biochip Market by Product
Microarrays (Array-Based Biochips)
Microfluidic Biochips (Lab-on-a-Chip)
Biochip Equipment and Software
Biochip Consumables and Kits
Global Biochip Market by Technology
Microarray Technology
Microfluidics Technology
Global Biochip Market by Application
Genomics
Proteomics
Disease Diagnostics
Drug Discovery and Development
Global Biochip Market by End User
Academic and Research Institutes
Biopharmaceutical Companies
Hospitals and Diagnostic Centers
Geographic Breakdown
Global Biochip Market by Region
Market Size and Forecast
North America
Europe
Asia-Pacific
Rest of World (ROW)

Chapter 7 Competitive Intelligence

Industry Structure
Breakthrough Technologies and Product Launches
Top Company Rankings
Key Strategies Adopted by Companies
Collaborations and Partnerships
New Product Launch
Expansion and Investment
Mergers and Acquisitions

Chapter 8 Sustainability in the Biochip Market: An ESG Perspective

Introduction to ESG
ESG Performance in the Biochip Market
ESG Practices in the Biochip Industry
Environmental Performance
Social Performance
Governance Performance
ESG Risk Ratings
Concluding Remarks from BCC Research

Chapter 9 Appendix

Methodology
Abbreviations
Company Profiles
ABBOTT
AGILENT TECHNOLOGIES INC.
BIOMERIEUX
BIO-RAD LABORATORIES INC.
F. HOFFMANN-LA ROCHE LTD.
IBIOCHIPS
ILLUMINA INC.
LI-COR BIOTECH LLC.
MICRONIT B.V.
NUTCRACKER THERAPEUTICS INC.
QIAGEN
RANDOX LABORATORIES LTD.
REVVITY
STANDARD BIOTOOLS
THERMO FISHER SCIENTIFIC INC.

Product Code: BIO049G

List of Tables

Summary Table : Global Biochip Market, by Product Type, Through 2029
Table 1 : Molecular Biology Technologies for Microarray Approaches
Table 2 : Global Biochip Market, by Product, Through 2029
Table 3 : Global Market for Microarrays , by Region, Through 2029($ Millions)
Table 4 : Global Market for Microarrays (Array-Based Biochips), by Product, Through 2029
Table 5 : Global Market for DNA Microarrays, by Region, Through 2029
Table 6 : Commercially Available Protein Microarrays
Table 7 : Global Market for Protein Microarrays, by Region, Through 2029
Table 8 : Global Market for Peptide/Tissue/Other Specialty Microarrays, by Region, Through 2029
Table 9 : Global Market for Microfluidic Biochips (Lab-on-a-Chip), by Region, Through 2029
Table 10 : Global Market for Microfluidic Biochips (Lab-on-a-Chip), by Product, Through 2029
Table 11 : Global Market for Microfluidic Chips, by Region, Through 2029
Table 12 : Global Market for Organ-on-a-Chip, by Region, Through 2029
Table 13 : Global Market for Biochip Equipment and Software, by Region, Through 2029
Table 14 : Global Market for Biochip Equipment and Software, by Product, Through 2029
Table 15 : Global Market for Biochip Sample Preparation Equipment, by Region, Through 2029
Table 16 : Global Market for Biochip Array Processing Equipment, by Region, Through 2029
Table 17 : Global Market for Biochip Scanners and Imaging Systems, by Region, Through 2029
Table 18 : Global Market for Biochip Analysis Software, by Region, Through 2029
Table 19 : Global Market for Biochip Consumables and Kits, by Region, Through 2029
Table 20 : Global Market for Biochip Consumables and Kits, by Product, Through 2029
Table 21 : Global Market for Microarray Kits and Reagents, by Region, Through 2029
Table 22 : Global Market for Microfluidic Chip Kits, by Region, Through 2029
Table 23 : Global Market for Biochip Sensors and Probes, by Region, Through 2029
Table 24 : Global Market for Biochips, by Technology, Through 2029
Table 25 : Global Biochip Market for Microarray Technology, by Region, Through 2029
Table 26 : Global Biochip Market for Microfluidics Technology, by Region, Through 2029
Table 27 : Global Biochip Market, by Application, Through 2029
Table 28 : Global Biochip Market for Genomics, by Region, Through 2029
Table 29 : Global Biochip Market for Proteomics, by Region, Through 2029
Table 30 : Global Biochip Market for Disease Diagnostics, by Region, Through 2029
Table 31 : Global Biochip Market for Drug Discovery and Development, by Region, Through 2029
Table 32 : Global Biochip Market, by End User, Through 2029
Table 33 : Global Biochip Market for Academic and Research Institutes, by Region, Through 2029
Table 34 : Global Biochip Market for Biopharmaceutical Companies, by Region, Through 2029
Table 35 : Global Biochip Market for Hospitals and Diagnostic Centers, by Region, Through 2029
Table 36 : Global Biochip Market, by Region, Through 2029
Table 37 : North American Biochip Market, by Country, Through 2029
Table 38 : North American Biochip Market, by Product, Through 2029
Table 39 : North American Biochip Market for Microarrays (Array-Based Biochips), by Product, Through 2029
Table 40 : North American Biochip Market for Microfluidic Biochips (Lab-on-a-Chip), by Product, Through 2029
Table 41 : North American Biochip Market for Equipment and Software, by Product, Through 2029
Table 42 : North American Biochip Market for Consumables and Kits, by Product, Through 2029
Table 43 : North American Biochip Market, by Technology, Through 2029
Table 44 : North American Biochip Market, by Application, Through 2029
Table 45 : North American Biochip Market, by End User, Through 2029
Table 46 : European Biochip Market, by Country, Through 2029
Table 47 : European Biochip Market, by Product, Through 2029
Table 48 : European Biochip Market for Microarrays (Array-Based Biochips), by Product 2029
Table 49 : European Biochip Market for Microfluidic Biochips (Lab-on-a-Chip), by Product, Through 2029
Table 50 : European Biochip Market for Equipment and Software, by Product, Through 2029
Table 51 : European Biochip Market for Consumables and Kits, by Product, Through 2029
Table 52 : European Biochip Market, by Technology, Through 2029
Table 53 : European Biochip Market, by Application, Through 2029
Table 54 : European Biochip Market, by End User, Through 2029
Table 55 : Asia-Pacific Biochip Market, by Country, Through 2029
Table 56 : Asia-Pacific Biochip Market, by Product, Through 2029
Table 57 : Asia-Pacific Biochip Market for Microarrays (Array-Based Biochips), by Product, Through 2029
Table 58 : Asia-Pacific Biochip Market for Microfluidic Biochips (Lab-on-a-Chip), by Product, Through 2029
Table 59 : Asia-Pacific Biochip Market for Equipment and Software, by Product,Through 2029
Table 60 : Asia-Pacific Biochip Market for Consumables and Kits, by Product,Through 2029
Table 61 : Asia-Pacific Biochip Market, by Technology, Through 2029
Table 62 : Asia-Pacific Biochip Market, by Application, Through 2029
Table 63 : Asia-Pacific Biochip Market, by End User, Through 2029
Table 64 : ROW Biochip Market, by Product Type, Through 2029
Table 65 : ROW Biochip Market, by Technology, Through 2029
Table 66 : ROW Biochip Market, by Application, Through 2029
Table 67 : ROW Biochip Market, by End User, Through 2029
Table 68 : Top Companies in the Biochip Market, 2023
Table 69 : Collaborations and Partnerships in the Biochip Market, 2021-2024
Table 70 : Products Launches in the Biochip Market, 2021-2024
Table 71 : Expansion and Investments in the Biochip Market, 2021-2024
Table 72 : Mergers and Acquisitions in the Biochip Market, 2020-2024
Table 73 : Key Focus Areas in ESG Metrics
Table 74 : Environmental Performance Initiatives in the Biochip Market
Table 75 : Social Performance Initiatives in the Biochip Market
Table 76 : Governance Performance Initiatives in the Biochip Market
Table 77 : ESG Rankings for Biochip Companies, 2024*
Table 78 : Abbreviations Used in this Report
Table 79 : Abbott: Company Snapshot
Table 80 : Abbott: Financial Performance, FY 2023 and 2024
Table 81 : Abbott: Product Portfolio
Table 82 : Abbott: News/Key Developments, 2023 and 2024
Table 83 : Agilent Technologies Inc.: Company Snapshot
Table 84 : Agilent Technologies Inc.: Financial Performance, FY 2023 and 2024
Table 85 : Agilent Technologies Inc.: Product Portfolio
Table 86 : Agilent Technologies Inc.: News/Key Developments, 2023
Table 87 : BioMerieux: Company Snapshot
Table 88 : BioMerieux: Financial Performance, FY 2022 and 2023
Table 89 : BioMerieux: Product Portfolio
Table 90 : BioMerieux: News/Key Developments, 2024 and 2025
Table 91 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 92 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2023 and 2024
Table 93 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 94 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 95 : F. Hoffman-La Roche Ltd.: Financial Performance, FY 2023 and 2024
Table 96 : F. Hoffman-La Roche Ltd.: Product Portfolio
Table 97 : F. Hoffman-La Roche Ltd.: News/Key Developments, 2024 and 2025
Table 98 : iBioChips: Company Snapshot
Table 99 : iBioChips: Product Portfolio
Table 100 : Illumina Inc.: Company Snapshot
Table 101 : Illumina Inc.: Financial Performance, FY 2023 and 2024
Table 102 : Illumina Inc.: Product Portfolio
Table 103 : Illumina Inc.: News/Key Developments, 2023 and 2024
Table 104 : LI-COR Biotech LLC.: Company Snapshot
Table 105 : LI-COR Biotech LLC.: Product Portfolio
Table 106 : LI-COR Biotech LLC.: News/Key Developments, 2023 and 2024
Table 107 : Micronit B.V.: Company Snapshot
Table 108 : Micronit B.V.: Product Portfolio
Table 109 : Micronit B.V.: News/Key Developments, 2023
Table 110 : Nutcracker Therapeutics Inc.: Company Snapshot
Table 111 : Nutcracker Therapeutics Inc.: Product Portfolio
Table 112 : Nutcracker Therapeutics Inc.: News/Key Developments, 2022
Table 113 : Qiagen: Company Snapshot
Table 114 : Qiagen: Financial Performance, FY 2023 and 2024
Table 115 : Qiagen: Product Portfolio
Table 116 : Qiagen: News/Key Developments, 2023 and 2025
Table 117 : Randox Laboratories Ltd.: Company Snapshot
Table 118 : Randox Laboratories Ltd.: Product Portfolio
Table 119 : Randox Laboratories Ltd.: News/Key Developments, 2025
Table 120 : Revvity: Company Snapshot
Table 121 : Revvity: Financial Performance, FY 2023 and 2024
Table 122 : Revvity: Product Portfolio
Table 123 : Revvity: News/Key Developments, 2024 and 2025
Table 124 : Standard BioTools: Company Snapshot
Table 125 : Standard BioTools: Financial Performance, FY 2023 and 2024
Table 126 : Standard BioTools: Product Portfolio
Table 127 : Standard BioTools: News/Key Developments, 2022 and 2023
Table 128 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 129 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 130 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 131 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022 and 2024

List of Figures

Summary Figure : Global Shares of Biochip Market, by Product Type, 2023
Figure 1 : Market Dynamics of Global Biochip
Figure 2 : Global Shares of Biochip Market, by Product, 2023
Figure 3 : Global Shares of Biochip Market, by Technology, 2023
Figure 4 : Global Shares of Biochip Market, by Application, 2023
Figure 5 : Global Shares of Biochip Market, by End User, 2023
Figure 6 : Global Shares of Biochip Market, by Region, 2023
Figure 7 : North American Shares of Biochip Market, by Country, 2023
Figure 8 : European Shares of Biochip Market, by Country, 2023
Figure 9 : Asia-Pacific Shares of Biochip Market, by Country, 2023
Figure 10 : Snapshot of ESG Pillars
Figure 11 : Advantages of ESG for Companies
Figure 12 : Shares of Biotech Companies Providing ESG Disclosure, 2022
Figure 13 : Shares of ESG Disclosure Location of Biotech Companies, 2022
Figure 14 : ABBOTT: Revenue Share, by Business Unit, FY 2024
Figure 15 : ABBOTT: Revenue Share, by Country/Region, FY 2024
Figure 16 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2024
Figure 17 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2024
Figure 18 : BioMerieux: Revenue Share, by Business Unit, FY 2023
Figure 19 : BioMerieux: Revenue Share, by Country/Region, FY 2023
Figure 20 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2024
Figure 21 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2024
Figure 22 : F. Hoffman-La Roche Ltd.: Revenue Share, by Business Unit, FY 2024
Figure 23 : F. Hoffman-La Roche Ltd.: Revenue Share, by Country/Region, FY 2024
Figure 24 : Illumina Inc.: Revenue Share, by Business Unit, FY 2024
Figure 25 : Illumina Inc.: Revenue Share, by Country/Region, FY 2024
Figure 26 : QIAGEN: Revenue Share, by Business Unit, FY 2024
Figure 27 : QIAGEN: Revenue Share, by Country/Region, FY 2024
Figure 28 : REVVITY: Revenue Share, by Business Unit, FY 2024
Figure 29 : REVVITY: Revenue Share, by Country/Region, FY 2024
Figure 30 : Standard BioTools: Revenue Share, by Business Unit, FY 2024
Figure 31 : Standard BioTools: Revenue Share, by Country/Region, FY 2024
Figure 32 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2024
Figure 33 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2024

Global Biochip Markets: Microarrays and Lab-on-a-Chip

Description

Table of Contents

List of Tables

Report Scope

Report Includes

Table of Contents

Chapter 1 Executive Summary

Chapter 2 Market Overview

Chapter 3 Market Dynamics

Chapter 4 Regulatory Landscape

Chapter 5 Emerging Technologies and Developments

Chapter 6 Market Segmentation Analysis

Chapter 7 Competitive Intelligence

Chapter 8 Sustainability in the Biochip Market: An ESG Perspective

Chapter 9 Appendix

List of Tables

List of Figures